Is Viking Therapeutics Stock Going to $50? Bulls and Bears
A wide-open weight-loss drug market has investors buzzing about Viking Therapeutics. This article breaks down the bul...
An overview of how weight decay factors into index performance and the practical implications for index-following strategies.
28,490 articlesA wide-open weight-loss drug market has investors buzzing about Viking Therapeutics. This article breaks down the bul...
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Could Lilly ride a Nvidia-like surge? This piece analyzes whether the stock can follow Nvidia’s AI-driven momentum, f...
Two popular short-term corporate bond ETFs share many similarities, but subtle differences can matter for your portfo...
Two global asset managers, two different paths to growth. This analysis pits BlackRock and Invesco against each other...
A Qatar LNG outage and resilient U.S. shale growth have kept Henry Hub prices subdued, creating a rare price setup th...
Geopolitics can move markets fast. When tensions rise, like with Iran, volatility spikes and portfolios feel the stra...
Ripple breaks into a rare league of private unicorns, joining SpaceX and OpenAI. XRP trades around $1.40 as investors...
An 11% one-day slide in the SPDR S&P Semiconductor ETF underscores how equal-weight funds magnify single-name moves, ...
YieldMax's MSTY ETF continues to pay weekly distributions while its NAV slides, signaling rising risk for investors. ...
Investors chasing reliable profits often look for markets with strong rent demand and balanced growth. This article b...
Choosing between VEA and NZAC boils down to your priority: broad diversification in developed markets or a climate-al...